Laurimic (Fenticonazole Nitrate)

Fenticonazole nitrate blocks the fungal enzyme lanosterol 14α‑demethylase, which is essential for ergosterol synthesis. By disrupting ergosterol production, the drug compromises the fungal cell membrane, inhibiting growth and leading to the death of Candida organisms in the vagina.

The dosage regimen for Laurimic is determined by the prescribing healthcare professional based on the product’s labeling and the patient’s clinical condition. The prescriber will specify the number of applications, frequency, and duration of therapy.

Safety data for fenticonazole nitrate in pregnancy and lactation are limited, and the product is classified as having an unknown pregnancy category. It should only be used during pregnancy or while breastfeeding if the potential benefit justifies the potential risk, after consultation with a healthcare provider.

To order Laurimic, submit an enquiry on the product page at gnhindia.com, indicating the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide, and will request trade or institutional credentials before providing pricing, availability, shipping details, and any necessary import documentation.

Laurimic’s active ingredient, fenticonazole nitrate, offers a broad spectrum against Candida species and a longer residence time in the vaginal canal compared with some azole creams such as clotrimazole or miconazole. Clinical choice depends on factors like resistance patterns, patient tolerance, and prescriber preference.

Store Laurimic at room temperature, below 25 °C, in its original packaging. Keep the product away from moisture and direct sunlight, and ensure the container is tightly closed to maintain product stability.

Laurimic is applied intravaginally using the supplied applicator. The patient should follow the product instructions, inserting the dose deep into the vagina while lying down, and remain in that position for a few minutes to allow proper distribution.

Serious adverse reactions, although rare, include severe allergic responses such as rash, swelling, or hives, as well as life‑threatening skin conditions like Stevens‑Johnson syndrome, hepatic dysfunction, and severe vaginal ulceration. Any signs of these should prompt immediate medical attention.

Laurimic should not be used by individuals with a known hypersensitivity to fenticonazole nitrate or other imidazole antifungals. It is also contraindicated in patients who are currently using other medicated vaginal products without medical guidance.